These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 4117256

  • 1. New drugs on the horizon in bronchogenic carcinoma.
    Carter SK.
    Cancer; 1972 Nov; 30(5):1402-9. PubMed ID: 4117256
    [No Abstract] [Full Text] [Related]

  • 2. Bronchogenic carcinoma: new drugs available for study.
    Slavik M, Carter SK.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):265-9. PubMed ID: 4125744
    [No Abstract] [Full Text] [Related]

  • 3. Proceedings: Cancer of the prostate.
    Murphy GP.
    Cancer; 1973 Nov; 32(5):1089-91. PubMed ID: 4127978
    [No Abstract] [Full Text] [Related]

  • 4. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP, Gottlieb JA, Livingston R, Frei E.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract] [Full Text] [Related]

  • 5. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I.
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract] [Full Text] [Related]

  • 6. Preliminary report on the treatment of nonresectable cancer of the lung.
    Kaung DT, Wolf J, Hyde L, Zelen M.
    Cancer Chemother Rep; 1974 Mar; 58(3):359-64. PubMed ID: 4276322
    [No Abstract] [Full Text] [Related]

  • 7. New cancer chemotherapeutic agents.
    Burchenal JH, Carter SK.
    Cancer; 1972 Dec; 30(6):1639-46. PubMed ID: 4118405
    [No Abstract] [Full Text] [Related]

  • 8. The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
    Woodman RJ, Sirica AE, Gang M, Kline I, Venditti JM.
    Chemotherapy; 1973 Dec; 18(3):169-83. PubMed ID: 4119363
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H, Brugarolas A, Mittelman A, Vincent R.
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Chemotherapy in bronchogenic carcinoma (author's transl)].
    Bruntsch U.
    Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
    Ahmann DL, Bisel HF, Hahn RG.
    Cancer Chemother Rep; 1974 Apr; 58(6):861-5. PubMed ID: 4615785
    [No Abstract] [Full Text] [Related]

  • 18. An overview of the status of the nitrosoureas in other tumors.
    Carter SK.
    Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
    [No Abstract] [Full Text] [Related]

  • 19. BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.
    Whittington RM, Fairly JL, Majima H, Patno ME, Prentice R.
    Cancer Chemother Rep; 1972 Dec; 56(6):739-43. PubMed ID: 4574055
    [No Abstract] [Full Text] [Related]

  • 20. Cancer chemotherapy. II.
    Greenwald ES.
    N Y State J Med; 1972 Nov 01; 72(21):2641-54. PubMed ID: 4117677
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.